Compounds of Formula (I): ##STR00001## or pharmaceutically acceptable salts, solvates, or esters thereof, are useful in treating diseases or conditions mediated by CB.sub.1 receptors, such as metabolic syndrome and obesity, neuroinflammatory disorders, cognitive disorders and psychosis, addiction (e.g., smoking cessation), gastrointestinal disorders, and cardiovascular conditions.

 
Web www.patentalert.com

< Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine

> Gpr38 Receptor Agonists

> Synthesis and crystalline forms of NPY5 antagonist

~ 00599